Eli Lilly & Co. and Novo Nordisk A/S are competing for drug contracts in the aftermath of drug price scrutiny. Novo has managed to secure a contract with CVS, beating out its competitor. Other news is ...

Cigna (CI) unveils ENGUIDE, a specialized GLP-1 pharmacy to be launched next month as demand for obesity drugs like Wegovy ...

Analysts were rushing to reiterate their conviction in the stock following Thursday’s blow to Zepbound and Lilly shares.

The company’s health services division Evernorth is doubling down on a reliable growth area: assuaging payer concerns around ...

The company's experimental once-daily version will become the first oral GLP-1 for chronic weight management, if approved.

CVS Caremark has selected Novo Nordisk’s Wegovy as the preferred GLP-1 medication for its largest commercial template formularies, effective July 1. In March, Novo Nordisk launched NovoCare Pharmacy ...

NHS to trial prescribing the appetite-supressing drugs after a short consultation at a high street pharmacy as Government ...

Amgen AMGN reported first-quarter 2025 adjusted earnings of $4.90 per share, which beat the Zacks Consensus Estimate of $4.16 ...

With Wegovy in its portfolio, Novo Nordisk is a very good bet to continue being a winner. As it's currently considered something of an underdog, with its stock priced accordingly, it's also trading at ...

SwamCam®, a leader in AI-powered pool alarm systems, is proud to partner with Olympic gold medalist Lilly King to enhance ...

The sandwich chain has been losing restaurants in the U.S. for the last eight years in a row. In 2024, it closed 631 ...

Ingredient Plant-Based Ear Drop Supports Hearing Clarity, Eases Echoing and Ringing, and Offers a Natural Alternative to ...